Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regional Scalp Block With Ropivacaine 0.5% in Patients Undergoing Elective Craniotomy: a Prospective Randomized Controlled Trial

NCT03776617 is registered in ClinicalTrials.gov with George Papanicolaou Hospital as lead sponsor.

NCT NCT03776617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03776617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regional Scalp Block With Ropivacaine 0.5% in Patients Undergoing Elective Craniotomy: a Prospective Randomized Controlled Trial
Lead sponsor
George Papanicolaou Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 5, 2019
Completion date
December 31, 2019
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

craniotomy